• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估中枢神经系统临床试验中评估者的能力。

Evaluating rater competency for CNS clinical trials.

作者信息

Targum Steven D

机构信息

UBC-PharmaStar, Wayne, PA, USA.

出版信息

J Clin Psychopharmacol. 2006 Jun;26(3):308-10. doi: 10.1097/01.jcp.0000219049.33008.b7.

DOI:10.1097/01.jcp.0000219049.33008.b7
PMID:16702896
Abstract

Clinical trials rely on ratings accuracy to document a beneficial drug effect. This study examined rater competency with clinical nervous system rating instruments relative to previous clinical experience and participation in specific rater training programs. One thousand two hundred forty-one raters scored videotaped interviews of the Hamilton Anxiety Scale (HAM-A), Hamilton Depression Scale (HAM-D), and Young Mania Rating Scale (YMRS) during rater training programs conducted at 9 different investigator meetings. Scoring deviations relative to established acceptable scores were used to evaluate individual rater competency. Rater competency was not achieved by clinical experience alone. Previous clinical experience with mood-disordered patients ranged from none at all (18%) to 40 years in 1 rater. However, raters attending their first-ever training session (n = 485) were not differentiated on the basis of clinical experience on the HAM-A (P = 0.054), HAM-D (P = 0.06), or YMRS (P = 0.66). Alternatively, participation in repeated rater training sessions significantly improved rater competency on the HAM-A (P = 0.002), HAM-D (P < 0.001), and YMRS (P < 0.001). Furthermore, raters with clinical experience still improved with rater training. Using 5 years of clinical experience as a minimum cutoff (n = 795), raters who had participated in 5 or more training sessions significantly outperformed comparably experienced raters attending their first-ever training session on the HAM-A (P = 0.003), HAM-D (P < 0.001), and YMRS (P < 0.001). The findings show that rater training improves rater competency at all levels of clinical experience. Furthermore, more stringent criteria for rater eligibility and comprehensive rater training programs can improve ratings competency.

摘要

临床试验依赖评分准确性来记录药物的有益效果。本研究考察了评估者使用临床神经系统评分工具时的能力,以及他们此前的临床经验和参与特定评估者培训项目的情况。在9次不同的研究者会议上举办的评估者培训项目中,1241名评估者对汉密尔顿焦虑量表(HAM - A)、汉密尔顿抑郁量表(HAM - D)和杨氏躁狂评定量表(YMRS)的录像访谈进行了评分。相对于既定的可接受分数的评分偏差被用于评估个体评估者的能力。仅凭临床经验并不能使评估者达到所需能力。此前对情绪障碍患者的临床经验,从完全没有(18%)到1名评估者有40年不等。然而,首次参加培训课程的评估者(n = 485),在HAM - A(P = 0.054)、HAM - D(P = 0.06)或YMRS(P = 0.66)评分上,并未因临床经验而有所区分。相反,参与多次评估者培训课程显著提高了在HAM - A(P = 0.002)、HAM - D(P < 0.001)和YMRS(P < 0.001)上的评估者能力。此外,有临床经验的评估者在接受评估者培训后仍有提高。以5年临床经验作为最低界限(n = 795),参加过5次或更多培训课程的评估者,在HAM - A(P = 0.003)、HAM - D(P < 0.001)和YMRS(P < 0.001)上的表现显著优于首次参加培训课程的同等经验的评估者。研究结果表明,评估者培训能提高所有临床经验水平的评估者能力。此外,更严格的评估者资格标准和全面的评估者培训项目可以提高评分能力。

相似文献

1
Evaluating rater competency for CNS clinical trials.评估中枢神经系统临床试验中评估者的能力。
J Clin Psychopharmacol. 2006 Jun;26(3):308-10. doi: 10.1097/01.jcp.0000219049.33008.b7.
2
A novel approach to rater training and certification in multinational trials.跨国试验中评估者培训与认证的一种新方法。
Int Clin Psychopharmacol. 2007 Jul;22(4):187-91. doi: 10.1097/YIC.0b013e3280803dad.
3
Sources of unreliability in depression ratings.抑郁评分中不可靠性的来源。
J Clin Psychopharmacol. 2009 Feb;29(1):82-5. doi: 10.1097/JCP.0b013e318192e4d7.
4
Rater Training for a Multi-Site, International Clinical Trial: What Mood Symptoms may be most Difficult to Rate?多中心国际临床试验的评估者培训:哪些情绪症状可能最难评估?
Psychopharmacol Bull. 2011 Sep 15;44(3):5-14.
5
Mood disorders after stroke: diagnostic validation of the poststroke depression rating scale.中风后的情绪障碍:中风后抑郁评定量表的诊断效度
Cerebrovasc Dis. 2008;26(3):237-43. doi: 10.1159/000147450. Epub 2008 Jul 23.
6
Targeted scoring criteria reduce variance in global impressions.有针对性的评分标准可降低整体印象的差异。
Hum Psychopharmacol. 2008 Oct;23(7):629-33. doi: 10.1002/hup.966.
7
Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.喹硫平联合锂盐/丙戊酸盐治疗急性躁狂症的缓解/心境正常率。
J Affect Disord. 2007;100 Suppl 1:S55-63. doi: 10.1016/j.jad.2007.02.008. Epub 2007 Mar 26.
8
The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training.新型汉密尔顿抑郁量表(GRID)在培训前后,对于缺乏经验和经验丰富的评估者而言,均表现出了出色的评分者间信度。
Psychiatry Res. 2007 Sep 30;153(1):61-7. doi: 10.1016/j.psychres.2006.07.004. Epub 2007 Apr 18.
9
Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.文拉法辛与锂盐单药治疗双相II型重度抑郁发作的短期比较:一项随机开放标签研究。
J Clin Psychopharmacol. 2008 Apr;28(2):171-81. doi: 10.1097/JCP.0b013e318166c4e6.
10
A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.抗抑郁试验中临床总体印象变化的比较性荟萃分析。
J Nerv Ment Dis. 2006 Nov;194(11):845-52. doi: 10.1097/01.nmd.0000244554.91259.27.

引用本文的文献

1
Designing and Implementing a Web-Based Platform for Accurate and Reliable Clinical Outcome Measures and Global Certification for Evaluating Charcot-Marie-Tooth disease.设计并实施一个基于网络的平台,用于准确可靠的临床结果测量以及对遗传性运动感觉神经病进行评估的全球认证。
J Peripher Nerv Syst. 2025 Sep;30(3):e70062. doi: 10.1111/jns.70062.
2
Special Challenges in Pediatric Drug Development: First of Three Sets of Expanded Proceedings from the ISCTM Autumn Conference on Pediatric Drug Development.儿科药物研发中的特殊挑战:国际儿科药物研发与治疗学学会秋季会议三组扩充会议记录中的第一组
Innov Clin Neurosci. 2023 Jan-Mar;20(1-3):13-17.
3
Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases.
提高神经肌肉疾病评估与培训质量的共识指南
Front Genet. 2021 Nov 10;12:735936. doi: 10.3389/fgene.2021.735936. eCollection 2021.
4
Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III.用于随机临床试验SafeBoosC-III的近红外光谱监测在线培训模块的预试验。
Trials. 2020 Apr 23;21(1):356. doi: 10.1186/s13063-020-4206-6.
5
Audio-digital recordings for surveillance in clinical trials of major depressive disorder.用于重度抑郁症临床试验监测的音频数字记录。
Contemp Clin Trials Commun. 2019 Jan 8;14:100317. doi: 10.1016/j.conctc.2019.100317. eCollection 2019 Jun.
6
Ratings surveillance and reliability in a study of major depressive disorder with subthreshold hypomania (mixed features).在一项有亚阈值轻躁狂(混合特征)的重性抑郁障碍研究中进行的评定监测和可靠性研究。
Int J Methods Psychiatr Res. 2018 Dec;27(4):e1729. doi: 10.1002/mpr.1729. Epub 2018 Jun 26.
7
Rater Training for a Multi-Site, International Clinical Trial: What Mood Symptoms may be most Difficult to Rate?多中心国际临床试验的评估者培训:哪些情绪症状可能最难评估?
Psychopharmacol Bull. 2011 Sep 15;44(3):5-14.
8
Research staff training in a multisite randomized clinical trial: Methods and recommendations from the Stimulant Reduction Intervention using Dosed Exercise (STRIDE) trial.多中心随机临床试验中的研究人员培训:使用定量运动的兴奋剂减少干预(STRIDE)试验的方法与建议
Addict Res Theory. 2014;22(5):407-415. doi: 10.3109/16066359.2013.868446.
9
Alzheimer's disease drug development: old problems require new priorities.阿尔茨海默病药物研发:老问题需要新重点。
CNS Neurol Disord Drug Targets. 2008 Dec;7(6):499-511. doi: 10.2174/187152708787122950.
10
Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?为什么这么多治疗阿尔茨海默病的药物在研发中失败?是时候采用新方法和新实践了吗?
J Alzheimers Dis. 2008 Oct;15(2):303-25. doi: 10.3233/jad-2008-15213.